Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib
Article in Endocrine (April 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Endocrine (April 2024)
Article in Journal of Endocrinology (February 2024)
Article in American Journal of Cancer Research (January 2024)